Biography
My academic career began on completing a Ph.D at UCL, investigating the role of the gut-microbiota in the aetiology of Crohn’s disease. I have completed Postdocs in mucosal immunology at the Institute of Child Health and at The Rayne Institute at UCL; before joining King’s College London in 2012. My research interests are in mucosal barrier immunology, host-microbe interactions, and subsequent priming of adaptive immune responses. Investigating how these interactions go awry as a pathogenic cofactor in intestinal & liver diseases.
News
New approach to drug design promises hope in fight against antimicrobial resistance
Researchers from the Department of Chemistry develop breakthrough in the war against antimicrobial resistance.
'Poo transplant' trial provides hope for liver disease patients
The UK is to launch a clinical trial of a ‘poo transplant’ that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
King's hosts antimicrobial resistance awareness event at Westminster
On Tuesday 22nd March, King’s hosted the event Tackling Antimicrobial Resistance in Liver Disease in the Churchill Rooms at the Houses of Parliament.
News
New approach to drug design promises hope in fight against antimicrobial resistance
Researchers from the Department of Chemistry develop breakthrough in the war against antimicrobial resistance.
'Poo transplant' trial provides hope for liver disease patients
The UK is to launch a clinical trial of a ‘poo transplant’ that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
King's hosts antimicrobial resistance awareness event at Westminster
On Tuesday 22nd March, King’s hosted the event Tackling Antimicrobial Resistance in Liver Disease in the Churchill Rooms at the Houses of Parliament.